Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy × Thoracic × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 350 Lung Neoplasms 223 Small Cell Lung Carcinoma 62 Colorectal Neoplasms 57 Melanoma 45 Breast Neoplasms 45 Ovarian Neoplasms 43 Neoplasms 41 Neoplasm Metastasis 36 Pancreatic Neoplasms 31 Triple Negative Breast Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 23 Endometrial Neoplasms 22 Head and Neck Neoplasms 21 Prostatic Neoplasms 19 Carcinoma, Renal Cell 19 Stomach Neoplasms 18 Mesothelioma, Malignant 16 Uterine Cervical Neoplasms 15 Urinary Bladder Neoplasms 15 Esophageal Neoplasms 15 Mesothelioma 14 Colonic Neoplasms 14 Brain Neoplasms 14 Adenocarcinoma of Lung 13 Sarcoma 12 Carcinoma, Hepatocellular 12 Carcinoma 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Gastrointestinal Neoplasms 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡